Referanslar

1. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011 Dec 6;105 Suppl 2(Suppl 2):S77-81. [Crossref]  [PubMed]  [PMC]
2. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/ World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 1999 Jun;15(6):523-6. [PubMed]
3. Klurfeld DM, Kritchevsky D. Dietary fiber and hu- man cancer: critique of the literature. Adv Exp Med Biol. 1986;206:119-35. [Crossref]  [PubMed]
4. Block G, Patterson B, Subar A. Fruit, vegetables, and can- cer prevention: a review of the epidemiological evidence. Nutr Cancer. 1992;18(1):1-29. [Crossref]  [PubMed]
5. Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R. Patient use of dietary supplements: a clinician's perspec- tive. Curr Med Res Opin. 2008 Apr;24(4):1209-16. [Crossref]  [PubMed]
6. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans' views on the use and regulation of dietary supplements. Arch Intern Med. 2001 Mar 26;161(6):805-10. [Crossref]  [PubMed]
7. Prasad, S., Gupta, S.C., Aggarwal, B.B. (2012). Micronutrients and Cancer: Add Spice to Your Life. In: Shankar, S., Srivastava, R. (eds) Nutrition, Diet and Cancer. Springer, Dordrecht. [Crossref]
8. Mamede AC, Tavares SD, Abrantes AM, Trindade J, Maia JM, Botelho MF. The role of vitamins in cancer: a review. Nutr Cancer. 2011;63(4):479-94. [Crossref]  [PubMed]
9. Wu X, Cheng J, Wang X. Dietary Antioxidants: Potential An- ticancer Agents. Nutr Cancer. 2017 May-Jun;69(4):521-533. Epub 2017 Mar 31. [Crossref]  [PubMed]
10. Khuda-Bukhsh AR, Das S, Saha SK. Molecular ap- proaches toward targeted cancer prevention with some food plants and their products: inflammatory and other signal pathways. Nutr Cancer. 2014;66(2):194-205. Epub 2013 Dec 30. [Crossref]  [PubMed]
11. Campbell MJ, Trump DL. Vitamin D Receptor Signal- ing and Cancer. Endocrinol Metab Clin North Am. 2017 Dec;46(4):1009-1038. Epub2017 Sep 29. [Crossref]  [PubMed]  [PMC]
12. Jabbour J, Manana B, Zahreddine A, Al-Shaar L, Bazarba- chi A, Blaise D, El-Cheikh J. Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial. Bone Marrow Transplant. 2021 May;56(5):1106-1115. Epub 2020 [Crossref]  [PubMed]
13. Lopez-Delgado JC, Patel JJ, Stoppe C, McClave SA. Con- siderations for medical nutrition therapy management of the critically ill patient with hematological malignancies: A nar- rative review. Nutr Clin Pract. 2024 Apr 26. Epub ahead of print. [Crossref]  [PubMed]
14. Psaltopoulou T, Ntanasis-Stathopoulos I, Tsilimigras DI, Tzanninis IG, Gavriatopoulou M, Sergentanis TN. Micro- nutrient Intake and Risk of Hematological Malignancies in Adults: A Systematic Review and Meta-analysis of Co- hort Studies. Nutr Cancer. 2018 Aug-Sep;70(6):821-839. Epub 2018 Oct 5. [Crossref]  [PubMed]
15. Thompson CA, Habermann TM, Wang AH, Vierkant RA, Folsom AR, Ross JA, Cerhan JR. Antioxidant intake from fruits, vegetables and other sources and risk of non-Hod- gkin's lymphoma: the Iowa Women's Health Study. Int J Cancer. 2010 Feb 15;126(4):992-1003. [Crossref]  [PubMed]  [PMC]
16. World Cancer Research Fund, & American Institute for Cancer Research. (2007). Food, nutrition, physical ac- tivity, and the prevention of cancer: a global perspective (Vol. 1). American Institute for Cancer Research. [Link]
17. Hartge P, Lim U, Freedman DM, Colt JS, Cerhan JR, Cozen W, Severson RK, Davis S. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control. 2006 Oct;17(8):1045-52. [Crossref]  [PubMed]
18. Walter RB, Brasky TM, Milano F, White E. Vitamin, min- eral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2298-308. Epub 2011 Jul 29. [Crossref]  [PubMed]  [PMC]
19. Lopez-Delgado JC, Patel JJ, Stoppe C, McClave SA. Con- siderations for medical nutrition therapy management of the critically ill patient with hematological malignancies: A nar- rative review. Nutr Clin Pract. 2024 Apr 26. Epub ahead of print. [Crossref]  [PubMed]
20. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Fo- late deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3290-5. [Crossref]  [PubMed]  [PMC]
21. Krinsky NI, Johnson EJ. Carotenoid actions and their re- lation to health and disease. Mol Aspects Med. 2005 Dec;26(6):459-516. Epub2005 Nov 23. [Crossref]  [PubMed]
22. Huang HY, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer CR, Wilson RF, Cheng TY, Vassy J, Prokopowicz G, Barnes GJ 2nd, Bass EB. The efficacy and safety of mul- tivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a Nation- al Institutes of Health state-of-the-science conference. Ann Intern Med. 2006 Sep 5;145(5):372-85. Epub 2006 Jul 31. [Crossref]  [PubMed]
23. Walter RB, Brasky TM, Milano F, White E. Vitamin, min- eral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2298-308. Epub 2011 Jul 29. [Crossref]  [PubMed]  [PMC]
24. Psaltopoulou T, Ntanasis-Stathopoulos I, Tsilimigras DI, Tzanninis IG, Gavriatopoulou M, Sergentanis TN. Micro- nutrient Intake and Risk of Hematological Malignancies in Adults: A Systematic Review and Meta-analysis of Co- hort Studies. Nutr Cancer. 2018 Aug-Sep;70(6):821-839. Epub 2018 Oct 5. [Crossref]  [PubMed]
25. Wang W, Li G, He X, Gao J, Wang R, Wang Y, Zhao W. Serum 25-hydroxyvitamin D levels and prognosis in hema- tological malignancies: a systematic review and meta-anal- ysis. Cell Physiol Biochem. 2015;35(5):1999-2005. Epub 2015 Mar 27. [Crossref]  [PubMed]
26. Ito Y, Honda A, Kurokawa M. Impact of vitamin D lev- el at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis. Blood Adv. 2022 Mar 8;6(5):1499-1511. [Crossref]  [PubMed]  [PMC]
27. Potre C, Borsi E, Potre O, Ionita I, Samfireag M, Costaches- cu D, Secosan C, Lazar S, Ristescu AI. A Systematic Re- view Assessing the Impact of Vitamin D Levels on Adult Patients with Lymphoid Malignancies. Curr Oncol. 2023 Apr 20;30(4):4351-4364. [Crossref]  [PubMed]  [PMC]
28. Ammann EM, Drake MT, Haraldsson B, Wallace RB, Johnson KC, Desai P, Lin EM, Link BK. Incidence of he- matologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation. Cancer. 2017 Nov 1;123(21):4168-4177. Epub 2017Jun 27. [Crossref]  [PubMed]  [PMC]
29. Lu D, Chen J, Jin J. Vitamin D status and risk of non-Hod- gkin lymphoma: a meta-analysis. Cancer Causes Control. 2014 Nov;25(11):1553-63. Epub 2014 Aug 23. [Crossref]  [PubMed]
30. Kulling PM, Olson KC, Olson TL, Feith DJ, Loughran TP Jr. Vitamin D in hematological disorders and malignancies. Eur J Haematol. 2017 Mar;98(3):187-197. Epub 2016 Nov 21. [Crossref]  [PubMed]  [PMC]
31. Raoufinejad K, Shamshiri AR, Pezeshki S, Chahardouli B, Hadjibabaie M, Jahangard-Rafsanjani Z, Gholami K, Rajabi M, Vaezi M. Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a ran- domized clinical trial. Daru. 2019 Dec;27(2):709-720. Epub 2019 Nov 11. [Crossref]  [PubMed]  [PMC]
32. Mellibovsky L, Díez A, Pérez-Vila E, Serrano S, Nach- er M, Aubía J, Supervía A, Recker RR. Vitamin D treat- ment in myelodysplastic syndromes. Br J Haematol. 1998 Mar;100(3):516-20. [Crossref]  [PubMed]
33. Tongzhang Zheng, Theodore R. Holford, Brian Leaderer, Yawei Zhang, Shelia Hoar Zahm, Stuart Flynn, Giovanni Tallini, Bing Zhang, Kaiyong Zhou, Patricia H. Owens, Qing Lan, Nathaniel Rothman, Peter Boyle, Diet and Nu- trient Intakes and Risk of Non-Hodgkin's Lymphoma in Connecticut Women, American Journal of Epidemiology, Volume 159, Issue 5, 2004, 454-466. [PubMed]
34. Zhang SM, Hunter DJ, Rosner BA, Giovannucci EL, Colditz GA, Speizer FE, Willett WC. Intakes of fruits, veg- etables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers Prev. 2000 May;9(5):477-85. [PubMed]
35. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F; HAEMACARE Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE proj- ect. Blood. 2010 Nov 11;116(19):3724-34. Epub 2010 Jul 27. Erratum in: Blood. 2011 Mar 24;117(12):3477. [Crossref]  [PubMed]  [PMC]
36. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Ar- chimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Decon- inck E, Maloisel F, Castaigne S, Preudhomme C, Degos L. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood. 1999 Aug 15;94(4):1192-200. [Crossref]  [PubMed]
37. Brasky TM, White E, Chen CL. Long-Term, Supplemen- tal, One-Carbon Metabolism-Related Vitamin B Use in Re- lation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort. J Clin Oncol. 2017 Oct 20;35(30):3440- 3448. Epub 2017 Aug 22. [Crossref]  [PubMed]  [PMC]
38. Galluzzi L, Vacchelli E, Michels J, Garcia P, Kepp O, Se- novilla L, Vitale I, Kroemer G. Effects of vitamin B6 me- tabolism on oncogenesis, tumor progression and therapeutic responses. Oncogene. 2013 Oct 17;32(42):4995-5004. Epub 2013 Jan 21. [Crossref]  [PubMed]
39. Mikkelsen K, Prakash MD, Kuol N, Nurgali K, Stojanovs- ka L, Apostolopoulos V. Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells. Int J Mol Sci. 2019 Aug 1;20(15):3763. [Crossref]  [PubMed]  [PMC]
40. Zhou M, Xia J, Chen X, Wu T, Xu K, Zou Y, Zhang S, Guo P, Cheng H, Fida S, Song C. Assessing the causal associa- tion between dietary vitamin intake and lymphoma risk: a Mendelian randomisation study. Int J Food Sci Nutr. 2024 Feb;75(1):92-101. Epub 2023 Nov 7. [Crossref]  [PubMed]
41. Cao Y, Chen P, Cai M, Shi Q, Xu P, Wang L, He Y, Wang H, Zhao W. Prognostic impact of B-vitamins involved in one-carbon metabolism in patients with diffuse large B-cell lymphoma. Hematol Oncol. 2020 Oct;38(4):456-466. Epub 2020 Jun 26. [Crossref]  [PubMed]
42. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U SA. 1976 Oct;73(10):3685-9. [Crossref]  [PubMed]  [PMC]
43. Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with ad- vanced cancer. A controlled trial. N Engl J Med. 1979 Sep 27;301(13):687-90. [Crossref]  [PubMed]
44. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind com- parison. N Engl J Med. 1985 Jan 17;312(3):137-41. [Crossref]  [PubMed]
45. van Gorkom GNY, Boerenkamp LS, Gijsbers BLMG, van Ojik HH, Wodzig WKWH, Wieten L, Van Elssen CHMJ, Bos GMJ. No Effect of Vitamin C Administration on Neu- trophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Pla- cebo-Controlled Trial. Nutrients. 2022 Nov 11;14(22):4784. [Crossref]  [PubMed]  [PMC]
46. Mouchel PL, Bérard E, Tavitian S, Gadaud N, Vergez F, Rieu JB, Luquet I, Sarry A, Huguet F, Largeaud L, De- labesse E, Huynh A, Bertoli S, Récher C. Vitamin C and D supplementation in acute myeloid leukemia. Blood Adv. 2023 Nov 28;7(22):6886-6897. [Crossref]  [PubMed]  [PMC]
47. Rayman MP. The importance of selenium to human health. Lancet. 2000 Jul 15;356(9225):233-41. [Crossref]  [PubMed]
48. Ehudin MA, Golla U, Trivedi D, Potlakayala SD, Rudrabhat- la SV, Desai D, Dovat S, Claxton D, Sharma A. Therapeutic Benefits of Selenium in Hematological Malignancies. Int J Mol Sci. 2022 Jul 19;23(14):7972. [Crossref]  [PubMed]  [PMC]
49. Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R, Crespi CM. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. [Crossref]  [PubMed]  [PMC]
50. Asfour IA, El-Tehewi MM, Ahmed MH, Abdel-Sattar MA, Moustafa NN, Hegab HM, Fathey OM. High-dose sodium selenite can induce apoptosis of lymphoma cells in adult patients with non-Hodgkin's lymphoma. Biol Trace Elem Res. 2009 Mar;127(3):200-10. [Crossref]  [PubMed]
51. Jin Y, Cai L, Yang Q, Luo Z, Liang L, Liang Y, Wu B, Ding L, Zhang D, Xu X, Zhang L, Zhou F. Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helix -d-glucan. Carbohydr Polym. 2020 Jul 15;240:116329. [Crossref]  [PubMed]
52. Zuo XL, Chen JM, Zhou X, Li XZ, Mei GY. Levels of selenium, zinc, copper, and antioxidant enzyme activ- ity in patients with leukemia. Biol Trace Elem Res. 2006 Winter;114(1-3):41-53. [Crossref]  [PubMed]
53. Atieh M., Molouk H., AhmadReza S., Rocsanna N., Mohammad A., Ardeshir G. (2012). Trace Elements (Se, Zn, and Cu) Levels in Patients with Newly Diagnosed Acute Leukemia. International Journal of Hematology-Oncology and Stem Cell Research. 6. 5-10. [Link]
54. Last KW, Cornelius V, Delves T, Sieniawska C, Fitzgib- bon J, Norton A, Amess J, Wilson A, Rohatiner AZ, List- er TA. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2003 Jun 15;21(12):2335-41. [Crossref]  [PubMed]
55. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systemat- ic review. J Clin Oncol. 2008 Feb 1;26(4):665-73. [Crossref]  [PubMed]
56. Jahangard-Rafsanjani Z, Gholami K, Hadjibabaie M, Sham- shiri AR, Alimoghadam K, Sarayani A, Mojtahedzadeh M, Ostadali-Dehaghi M, Ghavamzadeh A. The efficacy of sele- nium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial. Bone Mar- row Transplant. 2013 Jun;48(6):832-6. [Crossref]  [PubMed]
57. Jameson MB, Evans SO. Adding selenium to chemotherapy and radiation in haematological malignancies: clinical tri- als are justified. Acta Haematol. 2014;132(2):254-5. [Crossref]  [PubMed]
58. Kaiafa GD, Saouli Z, Diamantidis MD, Kontoninas Z, Voulgaridou V, Raptaki M, Arampatzi S, Chatzidimitriou M, Perifanis V. Copper levels in patients with hematolog- ical malignancies. Eur J Intern Med. 2012 Dec;23(8):738-41. [Crossref]  [PubMed]
59. Hrgovcic M, Tessmer CF, Minckler TM, Mosier B, Tay- lor GH. Serum copper levels in lymphoma and leuke- mia. Special reference to Hodgkin's disease. Cancer. 1968 Apr;21(4):743-55. [Crossref]  [PubMed]
60. Saouli Z, Diamantidis MD, Papadopoulos A, Kaiafa G, Girtovitis FI, Kontoninas Z, et al. Copper levels in patients with hematological malignancies. Blood (ASH annual meeting abstracts), 112; 2008. p. 4885 [Crossref]
61. Zuo XL, Chen JM, Zhou X, Li XZ, Mei GY. Levels of selenium, zinc, copper, and antioxidant enzyme activ- ity in patients with leukemia. Biol Trace Elem Res. 2006 Winter;114(1-3):41-53. [Crossref]  [PubMed]
62. Demir C, Demir H, Esen R, Sehitogullari A, Atmaca M, AlayM. Altered serum levels of elements in acute leukemia cas- es in Turkey. Asian Pac J Cancer Prev. 2011;12(12):3471-4. [PubMed]
63. Sayani F, Desai P, Lanzkron S. Thalassemia, sickle cell dis- ease, and other hemoglobinopathies, American Society of Hematology Self-Assessment Program, Seventh Edition, 2019 [Link]
64. Koreth J, Antin JH. Iron overload in hematologic malig- nancies and outcome of allogeneic hematopoietic stem cell transplantation. Haematologica. 2010 Mar;95(3):364-6. [Crossref]  [PubMed]  [PMC]
65. Weber S, Parmon A, Kurrle N, Schnütgen F, Serve H. The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leu- kemia. Front Immunol. 2021 Feb 19;11:627662. [Crossref]  [PubMed]  [PMC]